Analysts/Institutional Investor Meet/Con. Call Updates

July 17, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Intimation of Investor Conference Call for Q1FY27 with Senior Management of Mankind Pharma Limited Pursuant to Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will host Investor Conference Call on Thursday, July 30, 2026 at 06:30 PM (IST) for Q1FY27. Details of the Investor Conference Call are enclosed herewith. The same are also being uploaded on website of the Company at www.mankindpharma.com. You are requested to kindly take the same on records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a Mankind Pharma Limited Earnings Call Invite | Q1 FY27 You are cordially invited to the Earnings Call, Scheduled on Thursday, 30th July 2026, at 06:30 PM IST, To discuss Q1 FY27 business performance and results: The details of the earnings call are as below: Earnings Call Details Date Thursday, 30th July 2026 Time 06:30 PM – 07:30 PM IST https://us06web.zoom.us/webinar/register/WN_gjCF6TrYR9eK24zP- Zoom Call RYSZQ Management will be represented by: - Mr. Rajeev Juneja – Vice Chairman & Managing Director - Mr. Sheetal Arora – Chief Executive Officer & Whole Time Director - Mr. Arjun Juneja - Chief Operating Officer - Mr. Sudipta Roy – Senior President – Sales & Marketing - Mr. Ashutosh Dhawan – Global Chief Financial Officer - Mr. Prakash Agarwal – President (Strategy) For details, please contact: Mankind Pharma Limited Adfactors PR Prakash Agarwal Snighter Albuquerque / Smit Shah E: Investor.relations@mankindpharma.com, E: Snighter.albuquerque@adfactorspr.com / T: 011 – 46846700 smit.shah@adfactorspr.com, M: +91 9870789596